Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00704496 · ClinicalTrials.gov registry record · Phase 3
The Effect of Pseudoephedrine on Rhinitis and Sleep
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 34
- Enrollment target
NCT00704496 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT00704496, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 34 participants
- Enrollment target
Study Summary
The hypothesis is that pseudoephedrine, a sympathomimetic amine commonly used as a decongestant, will decrease nasal congestion leading to increased patency of the nose and a decrease in nighttime sleep fragmentation in individuals with year round perennial allergic rhinitis (PAR). This decrease in sleep fragmentation will reduce daytime somnolence and fatigue.
Interventions
- DRUG Pseudoephedrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00704496
The ClinicalTrials.gov registry entry for NCT00704496 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pseudoephedrine is the first listed.
NCT00704496 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00704496 about?
NCT00704496 is a clinical study titled "The Effect of Pseudoephedrine on Rhinitis and Sleep". The hypothesis is that pseudoephedrine, a sympathomimetic amine commonly used as a decongestant, will decrease nasal congestion leading to increased patency of the nose and a decrease in nighttime sleep fragmentation in individuals with year round perennial allergic rhinitis (PAR). This decrease in ...
What is the current status of trial NCT00704496?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 34 participants. The study started on 2007-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00704496?
The interventions under investigation include: Pseudoephedrine (DRUG).
Who is sponsoring clinical trial NCT00704496?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.